Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
Aramark's Chief Executive Officer and director reported acquiring additional common shares through equity compensation. On 12/17/2025, the reporting person received 1,372.486 shares of Aramark common stock at a price of $0 per share. These shares represent dividend equivalent rights that accrued on previously granted restricted stock units and performance stock units in connection with the company’s quarterly dividend. After this transaction, the reporting person directly beneficially owns 1,018,634.844 shares of Aramark common stock.
Aramark reported an insider equity update for a director. On 12/17/2025, the director acquired 191.341 shares of common stock as dividend equivalent rights at a price of $0. These rights were credited in connection with Aramark’s quarterly dividend on deferred stock units already held by the director and will vest on the same schedule as the underlying awards.
After this transaction, the director beneficially owns 60,383.661 shares directly and 12,475 shares indirectly through a trust.
A director of Aramark reported an automatic credit of dividend-related stock units. On 12/17/2025, the reporting person acquired 36.372 common stock dividend equivalent rights at a price of $0. These rights accrued on deferred stock units in connection with Aramark’s quarterly dividend and vest on the same schedule as the underlying awards.
Following this transaction, the director beneficially owned 37,651.339 shares of Aramark common stock in direct ownership. The filing reflects routine dividend equivalents rather than an open-market purchase or sale.
Aramark reported a routine insider equity update for a director. On 12/17/2025, the reporting person received 96.688 shares of common stock as dividend equivalent rights tied to deferred stock units, at a stated price of $0 per share. These dividend equivalent rights vest on the same schedules as the underlying awards. After this transaction, the reporting person beneficially owned 30,513.088 shares of Aramark common stock in direct ownership.
Aramark reported a director-level insider transaction involving dividend equivalent rights on deferred stock units. On 12/17/2025, the reporting person acquired 75.633 shares of Aramark common stock at a price of $ 0, reflecting shares credited as dividend equivalents rather than an open-market purchase. Following this transaction, the insider beneficially owns 23,868.516 shares in direct form. The filing explains that these dividend equivalent rights arise from the issuer's quarterly dividend and vest on the same schedules as the underlying deferred stock unit awards.
Aramark director reported a small increase in their holdings of the company’s common stock through dividend-related awards. On 12/17/2025, the reporting person acquired 35.42 shares of common stock, recorded at a price of $0 per share, reflecting that this was an award rather than an open-market purchase.
After this transaction, the director beneficially owned 16,731.732 shares of Aramark common stock in direct ownership. The filing explains that these additional shares represent dividend equivalent rights, which are credited in connection with Aramark’s quarterly dividend on deferred stock units and vest on the same schedule as the underlying awards.
Aramark director reports additional stock from dividend equivalents. A director of Aramark reported receiving 255.993 shares of common stock on 12/17/2025, credited as dividend equivalent rights on deferred stock units. These rights arose from the company’s quarterly dividend and vest on the same schedule as the underlying deferred stock awards. Following this transaction, the director beneficially owns 94,298.114 Aramark common shares directly and 15,000 shares indirectly through a trust. The shares in this filing were acquired at a stated price of $0, reflecting a non-cash adjustment tied to existing compensation rather than an open-market purchase.
Aramark reported an insider equity change involving a company director. On 12/17/2025, the director acquired 136.134 shares of common stock at a price of $0. After this transaction, the director beneficially owned 42,961.657 shares of Aramark common stock in total.
According to the explanation, these additional shares represent dividend equivalent rights that accrued on deferred stock units the director already held, in connection with Aramark’s quarterly dividend. These dividend equivalent rights follow the same vesting schedule as the underlying deferred stock unit awards.
Aramark director reports automatic stock accrual from dividend equivalents. On 12/17/2025, a director of Aramark received 35.42 shares of common stock as dividend equivalent rights tied to the company’s quarterly dividend. These rights accrued on deferred stock units already held by the director and will vest on the same schedule as the underlying awards. The transaction was recorded at a price of $0, reflecting that it was an automatic dividend-related accrual rather than an open-market purchase. Following this transaction, the director beneficially owned 11,177.732 shares of Aramark common stock in direct ownership.
Aramark reported a routine insider ownership update. A director acquired 24.894 shares of common stock on 12/17/2025, reported with transaction code "A" for an acquisition. The shares were credited at a price of $0 as dividend equivalent rights tied to the company’s quarterly dividend on deferred stock units held by the director.
After this transaction, the director directly beneficially owned 7,991.184 shares of Aramark common stock. The dividend equivalent rights vest on the same schedule as the underlying deferred stock unit awards.
FAQ
What is the current stock price of Aramark US (ARMK)?
What is the market cap of Aramark US (ARMK)?
